Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped regrow hair in most patients with severe hair loss.

Higher IL-17A levels indicate more severe alopecia areata.

Red clover extract-based scalp treatments significantly improved hair volume and reduced hair loss and damage.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

Patients need better information about the risks of long-term steroid use.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

Lichen planus may be associated with a higher risk of metabolic syndrome.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Some drugs used to treat inflammation may cause hair loss.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

The CRH/CRH-R1 system might be involved in causing lichen planus.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Skin organoids are a promising new model for studying human skin development and testing treatments.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Unique fat cells near fibrotic areas contribute to systemic sclerosis progression.

Turmeric may improve knee osteoarthritis, depression, and metabolic syndrome, but evidence is weak.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.